X
Healthcare Jun 08, 2022 02:50 PM (GMT+8) · EqualOcean
On June 8, Novell health (6606.hk) and prenetics Group Limited (NASDAQ: pre) jointly held the launch conference of Changweiqing, a cancer early screening product, in Hong Kong, and announced that it planned to establish Novell health's first international R & D center in Hong Kong. It was revealed at the meeting that Chang Weiqing's official selling price in Hong Kong was HK $3000 / share. Consumers can visit the official website of coloclear by circle to make an appointment for offline or online consultation of prenetics cooperative clinic and experience the home sampling service. After the samples are delivered to the laboratory by express, the user can receive the test report within 5 working days. In addition, Zhuyeqing, CEO of nuofui health, said: "in line with the company's internationalization process, we are preparing to build nuofui health's first international R & D center in Hong Kong, focusing on multi omics cancer screening technology innovation and product development including second-generation sequencing technology (NGS)."

This text is a result of machine translation.